$2.52
-0.0100-0.40%
Pre-Market: 4:09 PM EDT
15 minutes delayed
Oramed Pharmaceuticals
ORMPNASDAQ
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock, Earnings Estimates, EPS, And Revenue
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$0.010
Quarterly Revenue Estimate
$250K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$674K
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals | -$0.03 | $0.01 | — | — | $674.00K | $250.00K | — | — | 08/08/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.08 | $0.02 | $0.04 | 100.00% | $666.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | $0.22 | -$0.12 | $0.33 | 375.00% | $681.00K | $0.00 | $0.00 | — | 03/06/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.18 | -$0.08 | -$0.08 | 0.00% | $682.00K | $700.00K | $0.00 | -100.00% | 11/09/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.11 | -$0.03 | 72.73% | $1.34M | $700.00K | $674.00K | -3.71% | 08/10/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.26 | -$0.08 | 69.23% | $666.00K | $750.00K | $666.00K | -11.20% | 05/11/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | $0.22 | 215.79% | $683.00K | $2.95M | $681.00K | -76.92% | 03/06/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.25 | -$0.18 | 28.00% | $681.00K | $690.00K | $682.00K | -1.16% | 11/10/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.22 | -$0.27 | -22.73% | $665.00K | — | $674.00K | — | 08/10/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.23 | -$0.27 | -17.39% | $674.00K | — | $666.00K | — | 05/12/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.16 | -$0.22 | -37.50% | $674.00K | $700.00K | $674.00K | -3.71% | 01/11/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.10 | -$0.10 | -$0.21 | -110.00% | $681.00K | — | $683.00K | — | 11/24/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | $0.10 | -$0.20 | -$0.17 | 15.00% | $681.00K | $970.00K | $681.00K | -29.79% | 07/14/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | -$0.17 | 10.53% | $674.00K | — | $665.00K | — | 04/13/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.15 | -$0.14 | -$0.23 | -64.29% | $674.00K | $640.00K | $674.00K | 5.31% | 01/14/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.15 | -$0.10 | 33.33% | $681.00K | — | $681.00K | — | 11/24/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.15 | -$0.10 | 33.33% | $682.00K | — | $681.00K | — | 07/07/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.25 | -$0.21 | 16.00% | $666.00K | — | $674.00K | — | 04/06/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.25 | -$0.26 | -$0.15 | 42.31% | $674.00K | — | $674.00K | — | 01/09/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.18 | -$0.34 | -$0.23 | 32.35% | $617.00K | — | $681.00K | — | 11/27/2019 | Get Alert |
Oramed Pharmaceuticals (ORMP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $0.04 | $0.02 | 100.0 % |
| Dec 2023 | 2024-03-06 | $0.33 | $-0.12 | 375.0 % |
| Sep 2023 | 2023-11-09 | $-0.08 | $-0.08 | 0.00 % |
| Jun 2023 | 2023-08-10 | $-0.03 | $-0.11 | 72.7 % |
Oramed Pharmaceuticals (ORMP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-09 | $0 | $700.00K | -100.0 % |
| Jun 2023 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
| Mar 2023 | 2023-05-11 | $666.00K | $750.00K | -11.2 % |
| Dec 2022 | 2023-03-06 | $681.00K | $2.95M | -76.9 % |
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
The Actual EPS was $0.04, which beat the estimate of $0.02.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.